Global Contract Biomanufacturing Services 麻豆原创 Research Report 2023

Publication ID:

PB504230402

Publication Date:

April 6, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Highlights
The global Contract Biomanufacturing Services market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Contract Biomanufacturing Services is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Contract Biomanufacturing Services is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Contract Biomanufacturing Services in Clinical Laboratory is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Contract Biomanufacturing Services include Abzena, Albany Molecular, Boehringer Ingelheim, Catalent, Charles River, Fujifilm, Horizon, Innovent Biologics and Jhl Biotech, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Contract Biomanufacturing Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Contract Biomanufacturing Services.
The Contract Biomanufacturing Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Contract Biomanufacturing Services market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Contract Biomanufacturing Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Abzena
Albany Molecular
Boehringer Ingelheim
Catalent
Charles River
Fujifilm
Horizon
Innovent Biologics
Jhl Biotech
Lonza
Merck
Segment by Type
Cooperative Manufacturing
Outsourcing
Segment by Application
Clinical Laboratory
Medical Company
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Contract Biomanufacturing Services companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Contract Biomanufacturing Services 麻豆原创 Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Cooperative Manufacturing
1.2.3 Outsourcing
1.3 麻豆原创 by Application
1.3.1 Global Contract Biomanufacturing Services 麻豆原创 Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Clinical Laboratory
1.3.3 Medical Company
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Contract Biomanufacturing Services 麻豆原创 Perspective (2018-2029)
2.2 Contract Biomanufacturing Services Growth Trends by Region
2.2.1 Global Contract Biomanufacturing Services 麻豆原创 Size by Region: 2018 VS 2022 VS 2029
2.2.2 Contract Biomanufacturing Services Historic 麻豆原创 Size by Region (2018-2023)
2.2.3 Contract Biomanufacturing Services Forecasted 麻豆原创 Size by Region (2024-2029)
2.3 Contract Biomanufacturing Services 麻豆原创 Dynamics
2.3.1 Contract Biomanufacturing Services Industry Trends
2.3.2 Contract Biomanufacturing Services 麻豆原创 Drivers
2.3.3 Contract Biomanufacturing Services 麻豆原创 Challenges
2.3.4 Contract Biomanufacturing Services 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Contract Biomanufacturing Services Players by Revenue
3.1.1 Global Top Contract Biomanufacturing Services Players by Revenue (2018-2023)
3.1.2 Global Contract Biomanufacturing Services Revenue 麻豆原创 Share by Players (2018-2023)
3.2 Global Contract Biomanufacturing Services 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Contract Biomanufacturing Services Revenue
3.4 Global Contract Biomanufacturing Services 麻豆原创 Concentration Ratio
3.4.1 Global Contract Biomanufacturing Services 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Contract Biomanufacturing Services Revenue in 2022
3.5 Contract Biomanufacturing Services Key Players Head office and Area Served
3.6 Key Players Contract Biomanufacturing Services Product Solution and Service
3.7 Date of Enter into Contract Biomanufacturing Services 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Contract Biomanufacturing Services Breakdown Data by Type
4.1 Global Contract Biomanufacturing Services Historic 麻豆原创 Size by Type (2018-2023)
4.2 Global Contract Biomanufacturing Services Forecasted 麻豆原创 Size by Type (2024-2029)
5 Contract Biomanufacturing Services Breakdown Data by Application
5.1 Global Contract Biomanufacturing Services Historic 麻豆原创 Size by Application (2018-2023)
5.2 Global Contract Biomanufacturing Services Forecasted 麻豆原创 Size by Application (2024-2029)
6 North America
6.1 North America Contract Biomanufacturing Services 麻豆原创 Size (2018-2029)
6.2 North America Contract Biomanufacturing Services 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Contract Biomanufacturing Services 麻豆原创 Size by Country (2018-2023)
6.4 North America Contract Biomanufacturing Services 麻豆原创 Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Contract Biomanufacturing Services 麻豆原创 Size (2018-2029)
7.2 Europe Contract Biomanufacturing Services 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Contract Biomanufacturing Services 麻豆原创 Size by Country (2018-2023)
7.4 Europe Contract Biomanufacturing Services 麻豆原创 Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Contract Biomanufacturing Services 麻豆原创 Size (2018-2029)
8.2 Asia-Pacific Contract Biomanufacturing Services 麻豆原创 Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Contract Biomanufacturing Services 麻豆原创 Size by Region (2018-2023)
8.4 Asia-Pacific Contract Biomanufacturing Services 麻豆原创 Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Contract Biomanufacturing Services 麻豆原创 Size (2018-2029)
9.2 Latin America Contract Biomanufacturing Services 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Contract Biomanufacturing Services 麻豆原创 Size by Country (2018-2023)
9.4 Latin America Contract Biomanufacturing Services 麻豆原创 Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Contract Biomanufacturing Services 麻豆原创 Size (2018-2029)
10.2 Middle East & Africa Contract Biomanufacturing Services 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Contract Biomanufacturing Services 麻豆原创 Size by Country (2018-2023)
10.4 Middle East & Africa Contract Biomanufacturing Services 麻豆原创 Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abzena
11.1.1 Abzena Company Detail
11.1.2 Abzena Business Overview
11.1.3 Abzena Contract Biomanufacturing Services Introduction
11.1.4 Abzena Revenue in Contract Biomanufacturing Services Business (2018-2023)
11.1.5 Abzena Recent Development
11.2 Albany Molecular
11.2.1 Albany Molecular Company Detail
11.2.2 Albany Molecular Business Overview
11.2.3 Albany Molecular Contract Biomanufacturing Services Introduction
11.2.4 Albany Molecular Revenue in Contract Biomanufacturing Services Business (2018-2023)
11.2.5 Albany Molecular Recent Development
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Detail
11.3.2 Boehringer Ingelheim Business Overview
11.3.3 Boehringer Ingelheim Contract Biomanufacturing Services Introduction
11.3.4 Boehringer Ingelheim Revenue in Contract Biomanufacturing Services Business (2018-2023)
11.3.5 Boehringer Ingelheim Recent Development
11.4 Catalent
11.4.1 Catalent Company Detail
11.4.2 Catalent Business Overview
11.4.3 Catalent Contract Biomanufacturing Services Introduction
11.4.4 Catalent Revenue in Contract Biomanufacturing Services Business (2018-2023)
11.4.5 Catalent Recent Development
11.5 Charles River
11.5.1 Charles River Company Detail
11.5.2 Charles River Business Overview
11.5.3 Charles River Contract Biomanufacturing Services Introduction
11.5.4 Charles River Revenue in Contract Biomanufacturing Services Business (2018-2023)
11.5.5 Charles River Recent Development
11.6 Fujifilm
11.6.1 Fujifilm Company Detail
11.6.2 Fujifilm Business Overview
11.6.3 Fujifilm Contract Biomanufacturing Services Introduction
11.6.4 Fujifilm Revenue in Contract Biomanufacturing Services Business (2018-2023)
11.6.5 Fujifilm Recent Development
11.7 Horizon
11.7.1 Horizon Company Detail
11.7.2 Horizon Business Overview
11.7.3 Horizon Contract Biomanufacturing Services Introduction
11.7.4 Horizon Revenue in Contract Biomanufacturing Services Business (2018-2023)
11.7.5 Horizon Recent Development
11.8 Innovent Biologics
11.8.1 Innovent Biologics Company Detail
11.8.2 Innovent Biologics Business Overview
11.8.3 Innovent Biologics Contract Biomanufacturing Services Introduction
11.8.4 Innovent Biologics Revenue in Contract Biomanufacturing Services Business (2018-2023)
11.8.5 Innovent Biologics Recent Development
11.9 Jhl Biotech
11.9.1 Jhl Biotech Company Detail
11.9.2 Jhl Biotech Business Overview
11.9.3 Jhl Biotech Contract Biomanufacturing Services Introduction
11.9.4 Jhl Biotech Revenue in Contract Biomanufacturing Services Business (2018-2023)
11.9.5 Jhl Biotech Recent Development
11.10 Lonza
11.10.1 Lonza Company Detail
11.10.2 Lonza Business Overview
11.10.3 Lonza Contract Biomanufacturing Services Introduction
11.10.4 Lonza Revenue in Contract Biomanufacturing Services Business (2018-2023)
11.10.5 Lonza Recent Development
11.11 Merck
11.11.1 Merck Company Detail
11.11.2 Merck Business Overview
11.11.3 Merck Contract Biomanufacturing Services Introduction
11.11.4 Merck Revenue in Contract Biomanufacturing Services Business (2018-2023)
11.11.5 Merck Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Abzena
Albany Molecular
Boehringer Ingelheim
Catalent
Charles River
Fujifilm
Horizon
Innovent Biologics
Jhl Biotech
Lonza
Merck

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.